genomic DNA drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (41)
Papers in which this entity is mentioned.
- Enhancer activation from transposable elements in extrachromosomal DNA. (2025)
- Rapid brain tumor classification from sparse epigenomic data. (2025)
- MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
- Benchmarking short and long read polishing tools for nanopore assemblies: achieving near-perfect genomes for outbreak isolates. (2024)
- GCparagon: evaluating and correcting GC biases in cell-free DNA at the fragment level. (2023)
- At the dawn: cell-free DNA fragmentomics and gene regulation. (2022)
- Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. (2022)
- Single-cell genomic variation induced by mutational processes in cancer. (2022)
- Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
- A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas. (2021)
- Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X. (2020)
- Immuno-genomic landscape of osteosarcoma. (2020)
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
- Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
- Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. (2018)
- Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
- A pooled mutational analysis identifies ionizing radiation-associated mutational signatures conserved between mouse and human malignancies. (2017)
- Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
- Mapping and phasing of structural variation in patient genomes using nanopore sequencing. (2017)
- A method to reduce ancestry related germline false positives in tumor only somatic variant calling. (2017)
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
- Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- Clinical exome performance for reporting secondary genetic findings. (2015)
- CONSERTING: integrating copy-number analysis with structural-variation detection. (2015)
- Comprehensive genomic profiles of small cell lung cancer. (2015)
- Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. (2014)
- ACMG clinical laboratory standards for next-generation sequencing. (2013)
- Characterizing and measuring bias in sequence data. (2013)
- High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. (2012)
- HLA typing from RNA-Seq sequence reads. (2012)
- Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1. (2011)
- DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing. (2010)
- Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. (2010)
- High-resolution mapping of copy-number alterations with massively parallel sequencing. (2009)
- Rapid SNP discovery and genetic mapping using sequenced RAD markers. (2008)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| genomic dna | drug | 77 | 97 |